Who are we
Who is responsible for the Respiratory Health Initiative?
The Respiratory Health Initiative was independently developed by the Copenhagen Institute for Futures Studies and is validated by an external independent Steering Committee of experts in the respiratory and health policy spaces.
The Copenhagen Institute for Futures Studies was founded as an independent, non-profit think tank in Denmark in 1969. Today the Institute is a global entity, working for and with public, private, and academic organisations around the world. The Institute is a global leader in applying futures studies methods to solve strategic challenges.
The tools and insights published under the Respiratory Health Initiative have been validated by a steering committee of independent respiratory and health policy experts, who have used their expertise to provide support, guidance, and oversight during the development of the resources.
Sanofi and Regeneron initially commissioned the creation of the Severe Asthma Index and COPD Index, but the Copenhagen Institute for Futures Studies independently researched and subsequently developed all the insights and recommendations contained within the Respiratory Health Initiative. Financial support was provided by Sanofi and Regeneron. The Copenhagen Institute for Futures Studies owns the Respiratory Health Initiative and all tools and resources within it, unless otherwise stated. The Copenhagen Institute for Futures Studies is committed to keeping all resources and insights within the Respiratory Health Initiative entirely free and fully accessible to the public.
The Copenhagen Institute for Futures Studies is an independent, non-profit think tank
The Respiratory Health Initiative was independently developed by the Copenhagen Institute for Futures Studies and is validated by an external independent Steering Committee of experts in the respiratory and health policy spaces.
The Copenhagen Institute for Futures Studies was founded as an independent, non-profit think tank in Denmark in 1969. Today the Institute is a global entity, working for and with public, private, and academic organisations around the world. The Institute is a global leader in applying futures studies methods to solve strategic challenges.
The tools and insights published under the Respiratory Health Initiative have been validated by a steering committee of independent respiratory and health policy experts, who have used their expertise to provide support, guidance, and oversight during the development of the resources.
The Severe Asthma Index and COPD Index were developed with the unrestricted support of Sanofi and Regeneron. The Copenhagen Institute for Futures Studies independently researched and subsequently developed all the insights and recommendations contained within the Respiratory Health Initiative. The Copenhagen Institute for Futures Studies owns the Respiratory Health Initiative and all tools and resources within it, unless otherwise stated. The Copenhagen Institute for Futures Studies is committed to keeping all resources and insights within the Respiratory Health Initiative entirely free and fully accessible to the public.
Our Aims
The Respiratory Health Initiative aims to:
Improve
Improve health care decision making and prioritisation of chronic respiratory disease through the use of a broad set of data and insights
Identify
Identify good practices in respiratory health care and support the development of resilient, learning health systems
Provide
Provide stakeholders with a unified platform for accessing, exploring, and sharing insights
Drive
Drive the development of robust and future-oriented policies and strategies for chronic respiratory disease care
Highlight
Highlight the role of and need for equity in the development and delivery of respiratory health care
Empower
Empower and educate the public about the impact of chronic respiratory disease
COPD Steering Committee
The committee includes eight global COPD and health policy experts. The members were selected in order to balance clinical knowledge in COPD, patient organisation leadership, and expertise in health policy development and implementation.
Sir David Behan
Dr MeiLan Han, MD, MS
Susanna Palkonen
Prof Dr Chen Rongchang
Eric Sutherland
Dr Ioanna Tsiligianni
Siân Williams
Tonya Winders
Severe Asthma Steering Committee
The Severe Asthma Index is validated by a six-member external independent Steering Committee of experts in the respiratory and health policy spaces.
Professor Vibeke Backer, MD DMSci
Sir David Behan
Mark Levy
Prof. Dr. Arzu Yorgancıoğlu
Mikaela Odemyr